D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
KALV holding history
KalVista Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KALV overviewAll 13F holders of KALVFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −21,100−100.0% | Sold out | Holders |
| Q3 2025 | 21,100 | $257.0K | <0.1% | −4,620−18.0% | Reduced | Holders |
| Q2 2025 | 25,720 | $290.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 25,720 | $296.8K | <0.1% | −47,566−64.9% | Reduced | Holders |
| Q4 2024 | 73,286 | $620.7K | <0.1% | −16,643−18.5% | Reduced | Holders |
| Q3 2024 | 89,929 | $1.04M | <0.1% | −10,132−10.1% | Reduced | Holders |
| Q2 2024 | 100,061 | $1.18M | <0.1% | +12,968+14.9% | Added | Holders |
| Q1 2024 | 87,093 | $1.03M | <0.1% | −1,670−1.9% | Reduced | Holders |
| Q4 2023 | 88,763 | $1.09M | <0.1% | −26,519−23.0% | Reduced | Holders |
| Q3 2023 | 115,282 | $1.11M | <0.1% | −1,580−1.4% | Reduced | Holders |
| Q2 2023 | 116,862 | $1.05M | <0.1% | +71,198+155.9% | Added | Holders |
| Q1 2023 | 45,664 | $358.9K | <0.1% | +1,851+4.2% | Added | Holders |
| Q4 2022 | 43,813 | $296.2K | <0.1% | −456−1.0% | Reduced | Holders |
| Q3 2022 | 44,269 | $642.0K | <0.1% | −10,707−19.5% | Reduced | Holders |
| Q2 2022 | 54,976 | $541.0K | <0.1% | +54,976 | New | Holders |